Univariate survival analysis showed that the patients with Cbl-b expression, age, tumor size, lymph node metastasis, histological grade, stage, radiotherapy and trastuzumab therapy were associated with prognosis (p < 0.2). Here, CBLB is linked to metastatic malignant neoplasm in the lymph nodes.